Abstract
Background While voluntary medical male circumcision (VMMC) reduces the risk of HIV transmission by 60%, circumcision coverage falls short of the UNAIDS 90% target. We investigated whether behaviourally informed message framing increased demand for VMMC.
Setting Adult users of the MoyaApp, a data free application in South Africa, who viewed a form designed to generate interest in VMMC during August-November 2022.
Methods A quasi-experimental study was conducted to evaluate four MoyaApp VMMC intervention forms against the Standard of Care (SOC) form. All forms enabled users to provide contact details for follow-up engagement by a call centre. The primary outcome was the proportion of forms submitted. Secondary outcomes included successful contact with the user, VMMC bookings/referrals and confirmed circumcision. Multivariable ordinary least-squares regression was used for the analysis.
Results MoyaApp VMMC form viewers totalled 118,337 of which 6% submitted a form. Foot-in-the-Door form viewers were more likely (+1.3 percentage points, p<0.01) to submit a form compared to the SOC group (6.3%). Active Choice (-1.1 percentage points, p<0.01) and Reserved for You (-0.05 percentage points, p<0.05) form viewers were less likely to submit a form compared to SOC. Users submitting on Foot-in-the-Door were less likely to be booked/referred compared to SOC (-5 percentage points, p<0.05). There were no differences between the intervention and SOC forms for successful contact and circumcisions.
Conclusions Message framing using behavioural insights was able to nudge men to engage with VMMC services. However, more work is needed to understand how to convert initial interest into bookings and circumcisions.
Trial registration
South African Clinical Trials Registry DOH-27-062022-7811
Pan-African Clinical Trials Registry PACTR202112699416418
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
DOH-27-062022-7811 PACTR202112699416418
Funding Statement
This analysis was funded by the Bill and Melinda Gates Foundation INV-008318. The contents are the responsibility of the authors and do not necessarily reflect the views of the sponsor. LL was partially supported by the National Institute of Mental Health of the National Institutes of Health under grant number K01MH119923. The funders had no role in the study design, collection, analysis and interpretation of the data, in manuscript preparation or the decision to publish. We wish to acknowledge the support from the University of California, San Francisco International Traineeships in AIDS Prevention Studies ITAPS, U.S. NIMH, R25MH123256 and IAVI. This work was assisted in part by a CFAR-ARI HIV Research Boost Award from the UCSF AIDS Research Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, NIMH, FIC or other funding institutes.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Human Research Ethics Committee (Medical) of the University of the Witwatersrand, and the University of Pennsylvania, and Boston University institutional review boards. A waiver of informed consent was granted for the study which utilised anonymised administrative data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
